SCARB1 and ovarian cancer: A recent study with platinum resistant HGSC ovarian cancer cell lines OVCAR4 and OVCAR5 shows that it is possible to decrease the uptake of cholesterol through SR-B1 with treating the cells with synthetic SR-B1-targeting, HDL-mimicking nanoparticles, and that it leads to decreased cancer cell viability [117].